The Synthetic Construct
June 30, 2023
Next-gen synthetic biology approaches will improve TCR-T and CAR-T research
4 min read

False
June 30, 2023
Next-gen synthetic biology approaches will improve TCR-T and CAR-T research
4 min read
June 29, 2023
The case of Kathleen Folbigg shows how far the field has come, but there are still no medical interventions
4 min read
June 28, 2023
The Greek philosopher Heraclitus would have (most likely) agreed that QC and QA labs must be prepared for changes
5 min read
June 27, 2023
An insight into the complexities of Alzheimer’s disease and the ongoing pursuit for breakthrough therapies
12 min read
June 26, 2023
Are antibody drug conjugates (ADCs) finally about to live up to the “magic bullet” hype in cancer treatment?
15 min read
June 23, 2023
How do we prevent criminals from reusing primary packaging for counterfeit medicines? Labeling solutions and other creative concepts can help.
5 min read
June 23, 2023
Asahi Kasei Bioprocess – based in Chicago and owned by a Japanese company – supplies bioprocess equipment, consumables, and scientific support, and has always considered itself to be a future-facing company. With the biopharma industry increasingly realizing the importance of sustainability, Asahi Kasei Bioprocess is putting its best foot forward. We interview Clayton Weber, Systems Engineering Lead/ Sustainability Lead at Asahi Kasei Bioprocess, to learn more.
7 min read
June 22, 2023
Leading experts in the field offer insights on the pharma industry’s most exciting developments
3 min read
June 20, 2023
How quality control is getting smarter – but why it needs to be smarter still
1 min read
June 19, 2023
Germany-based CDMO Vetter received six nominations in the 2023 CDMO Leadership Awards. Here, Carsten Press shares his thoughts on the achievement.
2 min read
False
False
False